4Front Ventures Announces Upcoming Conference Participation

4Front Ventures Announces Upcoming Conference Participation

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company"), a vertically integrated, multi-state cannabis operator and retailer, today announced its participation in the following upcoming conferences:

  • Hall of Flowers Palm Springs: May 4-5, 2022
    The Company will host a booth for the duration of the trade show, showcasing 4Front's suite of brands, including a new live resin line as well as the latest products from Island Cannabis Co. 4Front's exhibit will be located at Arena Booth B116 and will be open to conference attendees.
  • Canaccord Genuity 2022 US Cannabis Symposium: May 11, 2022
    Andrew Thut , 4Front's Chief Investment Officer and Interim Chief Financial Officer, will host a company presentation for conference attendees on Wednesday, May 11 at 8:00am ET on Presentation Track 4. Management will also host one-on-one and small group meetings throughout the day.
  • The Jefferies Conference - NYC Cannabis Summit: June 2, 2022
    Mr. Thut will be available to host one-on-one and small group meetings on Thursday, June 2, 2022.

For more information or to schedule a one-on-one investor meeting, please contact 4Front's Investor Relations team at IR@4frontventures.com .

4Front Ventures Corp. ("4Front" or the "Company") ( CSE: FFNT ) ( OTCQX: FFNTF ) is a national, vertically integrated multi-state cannabis operator who owns or manages operations and facilities in strategic medical and adult-use cannabis markets, including California , Illinois , Massachusetts , Michigan and Washington . Since its founding in 2011, 4Front has built a strong reputation for its high standards and low-cost cultivation and production methodologies earned through a track record of success in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. To date, 4Front has successfully brought to market more than 20 different cannabis brands and over 1,800 products, which are strategically distributed through its fully owned and operated "Mission Dispensaries" and retail outlets in its core markets. As the Company continues to drive value for its shareholders, its team is applying its decade of expertise in the sector across the cannabis industry value chain and ecosystem. For more information, visit www.4frontventures.com .

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/4front-ventures-announces-upcoming-conference-participation-301537085.html

SOURCE 4Front

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/May2022/02/c9258.html

News Provided by Canada Newswire via QuoteMedia

FFNT:CNX
The Conversation (0)
4Front Ventures

4Front Ventures

Designed for longterm success across the United States.

Designed for longterm success across the United States. Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...

Latest Press Releases

Related News